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Abstract
The year 2020 will remain in the history for the diffusion of the 
COVID-19 virus, originating a pandemic on a world scale with over 
a million deaths. From the onset of the pandemic, the scientific 
community has made numerous efforts to design systems to detect 
the infected subjects in ever-faster times, allowing both to intervene 
on them, to avoid dangerous complications, and to contain the 
pandemic spreading. In this paper, we present an overview of different 
innovative technologies and devices fielded against the SARS-CoV-2 
virus. The various technologies applicable to the rapid and reliable 
detection of the COVID-19 virus have been explored. Specifically, 
several magnetic, electrochemical, and plasmonic biosensors 
have been proposed in the scientific literature, as an alternative 
to nucleic acid-based real-time reverse transcription Polymerase 
Chain Reaction (PCR) (RT-qPCR) assays, overcoming the limitations 
featuring this typology of tests (the need for expensive instruments 
and reagents, as well as of specialized staff, and their reliability). 
Furthermore, we investigated the IoT solutions and devices, reported 
on the market and in the scientific literature, to contain the pandemic 
spreading, by avoiding the contagion, acquiring the parameters of 
suspected users, and monitoring them during the quarantine period.
Keywords
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In this research work, different innovative systems 
will be proposed for the detection of SARS-CoV-2. 
The SARS-CoV-2 virus consists of four structural 
proteins, namely, spike (S), envelope (E), membrane 
(M), and nucleocapsid (N). The name coronavirus 
is due to the presence of spike glycoproteins S 
(the S1 subunit and the S2 subunit) on its surface/
envelope, just like a crown. Since the end of 2019, 
the COVID-19 virus has spread widely all over the 
world. In this field, the technology offers valid support 
for medical applications simplifying the work of 
the medical staff and improving the lifestyle of the 
patients (Gaetani et al., 2019, 2020; Lay-Ekuakille 
et al., 2019; Visconti et al., 2018). Thanks to the very 
recent studies carried out all over the world, we are 
going to have increasingly precise, portable, and non-
invasive devices, which will facilitate early detection of 
the virus. In this way, we will be able to obtain data 
from a large portion of the world population, leading 
to a better knowledge of the deadly virus and finding 
a definitive cure to destroy it.
The remainder of the paper is arranged into three 
sections; the second section analyses the current 
literature related to the existing technology (e.g., mag-
netic biosensors, electrochemical biosensors, and 
plasmonic biosensors) for rapid and reliable detection 
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of the COVID-19 virus (Charibaldi et al., 2018). 
Specifically, the drawbacks of current diagnostic 
methods are discussed, and the advantages of 
biosensor-based detection over conventional ones 
are highlighted. These technologies could enable 
the development of new plug-and-play systems to 
manage the outbreak and prevent future ones. The 
third section is focused on the latest devices and 
techniques proposed in the literature, and already on 
the market, for continuously monitoring the user’s vital 
signs, so preventing and eradicating the COVID-19 
or similar diseases (de Fazio et al., 2020; Jatmiko 
et al., 2019; Lassoued et al., 2018; Mbuthia et al., 2018; 
Visconti et al., 2019; Visconti et al., 2020). The study 
will also focus on describing related architectures, 
platforms, and applications of the considered devices 
and technologies. The fourth section reports a com-
parative analysis of the technologies and sensing 
systems discussed in the second section , highlighting 
their advantages and limitations, as well as describing 
potentialities and emerging perspectives to make them 
useful solutions for facing future pandemics.
State of the art on sensors and  
technologies for detecting patients 
affected by COVID-19 virus
During the COVID-19 pandemic, the demand for high 
sensitivity, low-cost, rapid, easy-to-use, and reliable 
disease testing tools is increasing more and more. 
Real-Time Reverse-Transcription Polymerise Chain 
Reaction (RT-PCR) is the actual rapid assay used for 
the current diagnostic tests for the SARS-CoV-2 virus, 
responsible for COVID-19 disease. The RT-PCR is a 
complex technique that requires expensive laboratory 
equipment and trained technicians to perform the test 
and can take up to 48 h to provide results. Also, this 
is not a very accurate technique, as demonstrated by 
studies that have found up to 30% false negative.
In this paragraph, at first, we analyze the biosensor 
technologies and related applications. Then we look at 
the various diagnostic techniques of the virus through 
their use, trying to compare the pros and cons. Several 
laboratories around the world are working to find 
new methods and developing alternative molecular 
diagnostic platforms. Among the others, bio-sensing 
technologies, magnetoresistive biosensors, electro-
chemical biosensors, and plas monic biosensors have 
attracted attention in the last years.
Wu et al. (2020) proposed an analysis of magnetic 
nano-sensors for virus and pathogen detection 
before COVID-19. They demonstrated that magnetic 
nano-sensors are more versatile and applicable for 
antibody, antigen, and nucleic acid detection.
In magnetic biosensors, the magnetic tags (usually 
magnetic nanoparticles-MNPs) are functionalized with 
antibodies or DNA/RNA probes that specifically bind 
to the target analyte. Therefore, the concentration 
of the target analyte is converted to the magnetic 
signals, generated by the magnetic tags. Compared to 
plasmonic, optical, and electrochemical biosensors, 
the magnetic ones exhibit low background noise, as 
most of the biological environment is non-magnetic. 
The sensor signal is also less influenced by the type 
of sample matrix, enabling accurate and reliable 
detection processes.
The magnetic biosensors are classified into three 
categories:
1. Magnetoresistance (MR) sensors,
2.  Magnetic Particle Spectroscopy (MPS) plat-
forms, and
3. Nuclear Magnetic Resonance (NMR) platforms.
MR was first discovered by William Thompson, 
who coined the term Anisotropic Magnetoresistance 
(AMR). The basic principle of MR-based devices 
is the variation of the resistivity of a material or a 
structure, as a function of an external magnetic field. 
Similarly, in the AMR, the resistivities of both Ni and 
Fe increase if the charge current is applied parallel to 
the magnetization direction. On the contrary, both Ni 
and Fe’s resistivities decrease if the charge current is 
applied perpendicular to the magnetization direction. 
However, the maximum resistance variation recorded 
from the AMR devices is approximately only 2%, 
which makes it unsuitable for most applications.
The Giant Magneto-Resistance (GMR) was first 
observed by Albert Fert and Peter Grunberg in the 
Fe/Cr multi-layers grown with molecular-beam epi taxy. 
This multi-layer structure exhibits a resistance change 
more significant than that of the AMR devices. In 
general, the GMR effect primarily takes place in multi-
layer structures with alternating ferromagnetic and non-
magnetic metallic layers. When the mag netizations 
of two adjacent ferromagnetic layers are parallel, the 
multi-layer structure shows low resis tance; instead, 
if the magnetizations are antiparallel, the structure 
exhibits a high-resistance. Although the GMR effect 
was primarily observed in a thin film or layered system, 
it has also been observed in other systems such as 
Co–Au, Co–Ag, and Fe–Ag granular films. GMR effect 
in granular films is strictly related to the spin-dependent 
interfacial scattering and inter-particle coupling, which 
can be exploited for biosensing purposes given their 
ability to adapt to the shapes of different biomolecules. 
Compared to other sensor types, the capability 
of flexible GMR sensors to respond to an external 
magnetic field makes them a perfect candidate for 
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wearable real-time body activity monitoring and the 
evaluation of drug-delivery effectiveness.
Baselt et al. (1998) reported the first GMR-based 
biosensor using the Bead Array Counter micro-array. 
They develop a sandwich immunoassay, shown in 
(Figure 1), where the capturing antibodies, specifically 
chosen for the target analytes (such as antigens from 
viruses/pathogens), are pre-functionalized on the GMR 
sensor surface.
Afterward, biofluid samples are added, and specific 
antibody–antigen bindings are created in the sensor 
area. Thus, the detection-antibody-functionalized 
MNPs are added to the GMR sensing areas, consti-
tuting the antibody–antigen–capture antibody com-
plexes (Figure 1). Therefore, the amount of MNPs 
captured to the proximity of the sensor surface is 
directly proportional to the number of antigens in the 
testing sample.
Wu et al. presented a portable GMR bio-detector, 
called Z-Lab, able to detect the Influenza-A Virus (IAV). 
This bio-detector reached a Limit of Detection (LOD) 
of 15 ng/mL for the H1N1 virus, and a 125 TCID50/mL 
LOD for the purified H3N2 variant virus (H3N2v), with 
an overall assay time lower than 10 min (Figure 2) (Wu 
et al., 2017, 2020). The electronic section includes a 
microcontroller, a 24-bit codec, a Wheatstone Bridge 
for adjusting the offset on the carrier signal, a coil driver, 
and a USB and Bluetooth communication section.
Another research group from the Stanford 
University reported a similar portable GMR-based 
system for COVID-19 assays, shown in Figure 3, 
detecting the human immunoglobulin G and M (IgG 
and IgM) antibodies with sensitivities in the range from 
0.07 to 0.33 nM (Choi et al., 2016).
The detection system includes three main com-
ponents, namely the reader station, disposable 
Figure 1: Sandwich immunoassay mechanism of a GMR biosensor forming a capture antibody–
target antigen–detection antibody–MNP complex (Wu et al., 2020).
Figure 2: Picture of the GMR-based hand-held device (a), and top view of the electronic section 
with highlighted the main components (b) (Wu et al., 2017, 2020).
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sensing cartridge, and smartphone interface. The 
sensing cartridge consists of an 8 × 8 GMR sensor 
array. When the cartridge is placed into the reader, the 
electrical resistance is recorded for each sensor in real-
time, and a suitable smartphone application shows the 
results. The reader station includes two Direct Digital 
Synthesis for generating sinusoidal signals to excite 
a Helmholtz coil and the GMR cartridge. The signal 
from the GMR sensor is amplified after the carrier is 
subtracted.
Magnetic Tunnel Junctions (MTJs) are based on 
stack structures similar to the GMR stacks, except 
that the adjacent ferromagnetic layers are separated 
by an insulating layer (usually an oxide). These sensors 
typology offers an improved MR response and higher 
sensitivity. However, the main issue of the MTJ sensor 
is its high intrinsic noise that limits the device sensitivity. 
Grancharov et al. (2005) reported the first-ever proof of 
Magnetic Tunnel Junctions (MTJs) as a biosensor. They 
demonstrated a unique antigen and DNA detection 
method at room temperature using mono-dispersed 
manganese ferrite nanoparticles as the magnetic 
tags. Li et al. (2016) propose a rapid detection system 
for the p24 HIV antigen in serum/plasma based on 
the MgO-based MTJ structure equipped with 20 nm 
magnetic carboxyl-group functionalized nanoparticles. 
In particular, the MJT array uses a sensing area equal 
to 890 × 890 µm2 for obtaining a detection sensitivity of 
the p24 antigen equal to 1.39%/Oe.
Unlike the MR sensors, the MPS technology 
is essentially volume-based, directly detecting the 
dynamic magnetic responses of MNPs, thus con-
stituting the only signal sources and indicators for 
probing the target analytes inside the non-magnetic 
media. Specifically, the MPS-based biotests exploit 
the nonlinear MNPs’ magnetic responses and their 
rotational spin, as detection indicators. This platform 
is characterized by external sinusoidal magnetic fields 
(namely excitation fields), which periodically magnetize 
(and magnetically saturate) the MNPs. Pick-up coils 
capture the time-varying dipolar magnetic fields 
generated by MNPs as a response to the applied fields. 
Then, the MPS spectra are extracted and analyzed.
There are two types of MPS-based immunoassay 
platforms: volume and surface-based platforms. Both 
techniques use the dynamic magnetic responses of 
MNPs for assay purposes, but with different degrees 
of freedom. In volume-based MPS platforms, MNPs 
are dispersed in the liquid phase, on which external 
magnetic fields are applied. The MNPs immersed in 
the biological/chemical reagents, such as antibodies 
(DNA, RNA, and proteins), act as high-specificity 
probes to capture target analytes present in the biofluid 
samples. The successful recognition and binding 
events on MNPs produce increased hydrodynamic 
volume. Due to the increased hydrodynamic volume, 
the Brownian relaxation of the MNPs into the solution 
is strongly reduced, and magnetic responses are 
also reduced. Moreover, phase lags between the 
magnetic moments and external fields are increased, 
whereas the MPS spectra show a reduction of the 
harmonic amplitudes.
Orlov et al. (2016) have demonstrated a surface-
based MPS platform with the lateral-flow measurement 
with multiplexed Lateral-Flow (LF) assay for the 
detection of botulinum neurotoxin (BoNT) types A, B, 
and E. The lateral flow method is applied using optical 
labels made of latex, Au, Ag, and QDs (Quantum 
Dots), which results in not high sensitivity. However, 
by replacing these optical labels with magnetic labels 
(i.e., MNPs), a high-sensitivity, high-stability, and low-
background-noise biosensing platform is achieved. 
Each test strip is named A-strip, B-strip, and E-strip, 
for detecting BoNT-A, -B, and -E, respectively. Each 
strip comprises a conjugation pad, overlapping sam-
ple pad, nitrocellulose, and wicking pad, all placed 
on an adhesive plastic backing sheet. The anti-
BoNT capture antibodies are deposited onto the 
nitrocellulose membrane labeled as test line and the 
corresponding MNP–detection antibody complexes 
are deposited on the conjugation pad (Figure 4).
The amplitudes of the magnetic signal recorded 
from the MPS are correlated with the concentration 
Figure 3: Picture of GMR-based portable 
device reported by the researchers from 
Stanford University (Choi et al., 2016).
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(quantity) of target analytes. Many other portable 
MPS immunoassay platforms have been created. 
For example, the platform, in ref. Pietschmann et al. 
(2020), is a surface-based immunoassay platform MInD 
(magnetic immunodetection) for the detection of SARS-
CoV-2-specific antibodies. In their work, a porous 
polyethylene filter matrix coated with a SARS-CoV-2 
spike–protein peptide acts as the reaction surface.
In another interesting work, Zhang et al. (2013) 
demonstrated the possibility of using a volume-
based MPS bioassay method for molecular sensing 
applications. The MNPs are functionalized with two 
antithrombin DNA aptamers; the target analytes (i.e., 
thrombin) link MNPs together through DNA–DNA 
interactions, inhibiting the rotational freedom of MNPs 
and thus reducing the magnetic responses. They 
showed a LOD of 4 nM and 2 pmol for the detection 
of thrombin. Besides, they also demonstrated the 
possibility of detecting a single-strand DNA (ssDNA) 
in the serum with a LOD of 400 pM. This pioneering 
work has indicated that volume-based MPSs repre-
sent a promising platform for versatile bioassay and 
highly sensitive for future applications.
Another category of magnetic biosensors is 
the NMR platform (also called Magnetic Relaxation 
Switching), which employ MNPs as contrast en-
hancers generating an inhomogeneity of the local 
magnetic field and perturbing the variations of 
precession frequency in millions of surrounding water 
protons (Blümich, 2016). Nuclei, such as Hydrogen 
(H), Carbon (C), and Phosphor (P) featured by an odd 
number of protons and/or neutrons exhibit intrinsic 
magnetic moments and thus possess nonzero spin. 
Whenever an external static magnetic field, H0, 
is applied along the z-direction, the nuclear spin 
behaves like a small magnetic bar and executes 
precession motions about the field direction with a 
Larmor frequency. Upon removal of this external field, 
the nuclear spins are randomized, showing 0 overall 
magnetization. When a Radio-Frequency (RF) pulse 
is applied orthogonal to the static field H0, these 
nuclei are flipped toward the x–y plane. A tipping 
angle of 90° (i.e., flipping the nuclear spins to the x–y 
plane) can maximize the resultant NMR signal in the 
transverse plane. When the RF pulse is removed, 
these nuclei relax back to equilibrium states. The 
RF coils monitor the transverse and longitudinal 
magnetizations of these nuclear spins, by measuring 
the related magnetic fluxes. The longitudinal relaxation 
time T1 is the time taken by the z component of the 
nuclear spin (magnetization) to come back to its 
thermal equilibrium value, whereas the transverse 
relaxation time T2 is the measure of the decay of net 
magnetization in the x–y plane (perpendicular to H0). 
The reciprocals of T1 and T2 indicated as R1 and R2, 
are the longitudinal and transverse relaxation rates.
In most applications, the NMR technique detects 
the MNP-labeled targets by measuring the precessional 
signal of the H proton into the entire sample volume 
(Orlov et al., 2016). In this way, the NMR platform can be 
classified as a volume-based immune assay method.
In recent years, there have been many advances in 
miniaturizing the NMR platforms such as assembling 
electronics into integrated-circuit chips, implementing 
smaller or planar NMR coils and compact permanent 
magnets, and mounting microfluidic channels (Hale 
Figure 4: Test-strip design and setup (Orlov et al., 2016).
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et al., 2018; Jeyaprakash and Mukesh, 2015; Smits 
et al., 2019). These low-cost micro NMR platforms 
(μ NMR) have demonstrated portability, robustness, 
versatility, and even higher sensitivity than conventional 
systems. With these capabilities, it is expected that an 
NMR hand-held device can be an essential tool for 
personal care and accurate diagnostics for infectious 
diseases in rural areas and mitigates the healthcare 
burden.
For example, Lei et al. (2015) presented a portable 
miniaturized micro-nuclear magnetic resonance re-
laxometer for automated multi-sample chemical/
biological analysis. The system integrates a small Tesla 
magnet for carrying out the NMR assay on biological 
samples probed by MNPs; the relaxation time is 
determined using multiplexed µNMR sampling. An 
integrated transceiver converts the magnetic signal, 
captured by the embedded coils, into an electric 
signal by analyzing sub-10 μ L samples. Carried 
out tests demonstrate that designed µNMR and 
employing biotinylated Iron NPs, 0.2 μ M sensitivity is 
reached. The advantages and disadvantages (without 
the assay sensitivity) of the afore-described platform 
are summarized and compared in Table 1.
Furthermore, each platform’s assay specificity 
depends on external factors such as the antibody 
typologies and the assay modalities; for this reason, 
the assay specificity of each platform is not listed or 
compared in Table 1.
In general, magnetic nano-sensors’ platforms are 
featured by easier sample preparation than standard 
optical techniques; they use safer magnetic labels 
Table 1. Advantages and disadvantages of different magnetic nano-sensors 
technologies (Wu et al., 2020).
Platform Advantages Disadvantages
GMR High sensitivity Multiple washing steps usually required, thus needing well-trained 
technicians, but can be wash-free, which reduces the sensitivity
Availability of a portable device Time-consuming
Mass production capability High cost per test; nanofabrication of GMR biosensors required
MTJ High sensitivity Multiple washing steps usually required, thus needing well-trained 
technicians, but can be wash-free, which reduces the sensitivity




High cost per test; nanofabrication of MTJ biosensors required
MPS, surface- 
based
High sensitivity Multiple washing steps usually required, thus needing well-trained 
technicians, but can be wash-free, which reduces the sensitivity
Low cost per test Time-consuming
Availability of a portable device
MPS, volume- 
based
One-step wash-free detection 
allowed
Medium sensitivity
Immunoassays that can be 
hand-held by non-technicians
Low cost per test
Availability of a portable device
NMR Availability of a portable device Multiple washing steps usually required, thus needing well-trained 
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than electrochemical techniques and produce more 
homogeneous detection than mechanical methods. 
Given these advantages, we expect them to replace 
or supplement the current diagnosis techniques that 
rely on non-magnetic strategies. This paradigm shift 
could contribute to better surveillance and control of 
SARS-CoV-2 infection in populations.
Zhao et al. (2021) developed an ultrasensitive 
electrochemical technology based on functionalized 
graphene oxide for detecting the SARS-CoV-2 
virus. Given that COVID-19 patients have no specific 
symptoms, SARS-CoV-2 detection is indispensable 
for an accurate diagnosis. Although the antibody-
based serological tests are convenient and rapid, 
the technological issues limit their applicability. Since 
these tests require to check the antibodies produced 
by the human organism against SARS-CoV-2 follo wing 
symptom onset, they take a substantial amount of time. 
Moreover, SARS-CoV-2 antibodies have significant 
cross-reactivity with the antibodies generated by other 
coronaviruses. For this reason, nucleic acid-based real-
time reverse transcription Polymerase Chain Reaction 
(PCR) (RT-qPCR) assays are worldwide employed for 
the virus RNA detection. However, RT-qPCR has some 
drawbacks since it requires expensive instruments 
and reagents, the need for trained personnel, and 
sometimes RT-qPCR detection kits produce false-
negative results (Afzal, 2020).
Electrochemical biosensors represent an alternative 
solution due to their advantages, such as low cost, 
high sensitivity, user-friendliness, and robustness. 
Among the nucleic acid biosensors, a super-sandwich-
type electrochemical biosensor has attracted a lot of 
attention for its high specificity and sensitivity. This 
biosensor is composed of a Capture Probe (CP), Label 
Probe (LP), Target Sequence, and Auxiliary Probe 
(AP). The 5- and 3-terminals of the target sequence 
are complementary to CP and LP, respectively, and 
the 5- and 3- regions of AP have complementary 
sequences with two different LP areas. The sequence-
specific detection can be obtained using CP and LP, 
and AP hybridizes many times with LP to produce 
long concatamers, resulting in higher sensitivity. The 
sensitivity can be enhanced by facilitating the LP with 
signal molecules through other molecules or materials. 
In this study, the authors developed a super-sandwich-
type electrochemical biosensor based on p-sulfocalix 
arene (SCX8) functionalized graphene (SCX8-RGO) to 
enrich TB for COVID-19 RNA detection through the 
following procedures:
•	 The CPs labeled with thiol were immobilized on 
the surfaces of the Au@Fe3O4 nanoparticles 
and formed CP/Au@Fe3O4 nanocomposites;
•	 The host-guest complexes (SCX8-TB) were im-
mobilized on RGO to form Au@SCX8-TB-RGO-
LP bioconjugate;
•	 The sandwich structure of ‘CPtarget-LP’ pro-
duced; and
•	 AP was introduced to create long concatam-
ers, as shown in Figure 5.
They developed a plug-and-play method to achieve 
an accurate, sensitive, and rapid detection of SARS-
CoV-2 samples from various clinical specimens with-
out RNA amplification, by using an electrochemical 
biosensor equipped with a smartphone, providing a 
simple and low-cost method for point-of-care testing 
(POCT) (Figure 5).
Primer pairs were synthesized by the sequences 
provided by the Chinese Center for Disease Control 
and Prevention (CDC) and used to amplify the 
ORF1ab gene in real-time PCR (qPCR). In specificity 
characterization, they aligned the genomes of SARS-
CoV-2 through the BLAST analysis of NCBI COVID 
resources, so a high conservation region was selected.
Then, the authors prepared A and B premixes (as 
shown in Figure 5) to detect SARS-CoV-2; afterward, 
they prepare detection samples by including artificial 
Figure 5: Schematic representation 
of SARS-CoV-2 detection using the 
electrochemical biosensor. (a) Prepare 
the premix A and B; (b) Process of 
electrochemical detection using a 
smartphone (Zhao et al., 2021).
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targets and clinical RNA samples. Since the RNA is 
easy to degrade, they synthesized the corresponding 
target sequences of ssDNA according to the published 
RNA sequences of SARS-CoV-2 for electrochemical 
detection. All the clinical samples used in this study 
were collected from the Second People’s Hospital of 
Yunnan Province. In particular, a total of 88 samples 
from 25 confirmed patients and eight patients infected 
by SARS-CoV-2 were considered and inactivated 
by heating them at 56°C for 30 min. All RNAs were 
extracted using a Tianlong DNA/RNA virus mini-kit, 
and the prepared samples were stored at −80°C 
before use.
Subsequently, they made electrochemical and RT-
qPCR measurements (using a commercial 2019-nCOV 
ORF1ab/N nucleic acid detection kit). They discovered 
that a p-value lower than 0.05 was statistically sig-
nificant and indicated that the sample is positive. 
Later, the authors analyzed the characterization of 
nanocomposites, and all the results displayed the 
successful preparation of the RGO-SCX8-Au nano-
composites. RT-qPCR results highlighted that 35 of 62 
specimens were positive from the confirmed patients 
(56.5%), and two of 26 samples from the hospitalized 
patients (7.7%) were present. Therefore, the detectable 
positive rate was equal to 85.5%, thus demonstrating 
that the electrochemical test is more sensitive than the 
RT-qPCR assay for SARS-CoV-2 detection. Also note 
that, compared to the RT-qPCR assay, the developed 
SARS-CoV-2 biosensor was superior to other assays 
in detecting upper respiratory samples.
The proposed SARS-CoV-2 biosensor presented 
high sensitivity and specificity thanks to the following 
factors:
•	 The use of the super-sandwich-type electro-
chemical biosensor improve the specificity and 
increased signal enrichment ability;
•	 Many nanomaterials of high conductivity pro-
mote the signal intensity; and
•	 Super-molecular recognition plays an impor-
tant role in the enrichment of molecule TB for 
improving the sensitivity of the biosensor.
To ensure detection accuracy, they initially per-
formed homology analyses of their designed CP 
sequences targeting SARS-CoV-2 in silicon. After 
the alignment of 2,291 complete genomes of SARS-
CoV-2 obtained from the GenBank databases, the 
results showed that the SARS-CoV-2 RNA sequences 
binding to CP were completely conserved (100%).
Vadlamani et al. (2020) reported the synthesis of 
a cheap and highly sensitive electrochemical sen-
sor based on cobalt-functionalized TiO2 nanotubes 
(Co-TNTs) for quick detection of SARS-CoV-2 
through sensing the spike protein (receptor-binding 
domain (RBD)) present on the surface of the virus. A 
low-cost and straightforward electrochemical ano-
dizing technique was used for synthesizing TNTs, 
followed by an incipient wetting method for cobalt 
functionalization of the TNTs, then connected to a 
potentiostat for the signal collection. This sensor 
detects the S-RBD protein of SARS-CoV-2 even at 
very low concentration (ranged from 14 to 1,400 nM 
(nanomolar)) featured by a linear response in detecting 
viral protein within the concentration range. Thus, 
their Co-TNT sensor is very effective in detecting 
SARS-CoV-2 S-RBD protein, approximately in 30 s.
The main issues of the actual diagnostic tests are 
their invasive nature, requiring trained personal for 
nasopharyngeal sample collection, along with the 
requirement of highly sophisticated machines, cross-
reactivity with other viruses, and a longer duration 
of testing. Electrochemical biosensors are based on 
electrode material and form factor, and widely used 
for virus detection based on aptamers, antibodies, 
and imprinted polymers. Also, these sensors have 
the advantage of being sensitive to biomolecules due 
to their ability to detect biomarkers with specificity, 
accuracy, and high sensitivity. Electrochemical bio-
sensors have already been successfully used in 
medical diagnostics for the detection of other viruses, 
like the Middle East respiratory syndrome coronavirus 
(MERS-CoV), the human influenza A virus H9N2, the 
human enterovirus 71 (EV71), and the avian influenza 
virus (AIV) H5N1. Electrochemical biosensor operation 
can be improved by nano-structuring the electrode, 
increasing the electrochemical reaction rate thanks to 
the larger electrode surface area to volume ratio, and 
in this way, the electrode surface area exposed to the 
analyte fluid volume.
Chin et al. (2017) proposed a detection mechanism 
based on the formation, upon the nanostructured 
carbon electrodes, of a complex between Cobalt (Co) 
and the biomarker at a specific bias voltage, because 
of the reduction of Co ions oxidation of the biomarker. 
Similarly, the SARS-CoV-2 can be detected through 
complexing of functionalized nanoparticles with the 
S-RBD protein (Figure 6) (Vadlamani et al., 2020).
The data show that cobalt functionalized TNTs 
can selectively detect the S-RBD protein of COVID-19 
using the amperometry electrochemical technique. At 
first, the TNTs were synthesized by electrochemical 
anodization of the Ti sheet. Afterward, this was cut 
out of a G1 grade Ti sheet (thickness ∼ 10 µm), and 
one side was polished to remove any surface metal 
oxide layer. The coupon was ultrasonicated, and the 
unpolished side was masked with Kapton tape to 
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Figure 6: Schematic of Co-functionalized 
TiO2 nanotube (Co-TNT)-based sensing 
platform for detecting SARS-CoV-2 
(Vadlamani et al., 2020).
prevent any exposure to electrolyte during anodization. 
Therefore, the electrochemical anodization was per-
formed in a standard two-electrode configuration, 
and then, the anodization carried out. The sample 
was rinsed, and the Kapton tape was removed from 
sample after baking; finally, it was cooked again in a 
tube furnace at 500°C for 3 h.
The annealed TNTs were functionalized with 
cobalt using an incipient wetting method; then, the 
same side of the sample was masked again with 
Kapton tape and ultrasonicated for 35 min. Therefore, 
the sample was baked in an oven at 120°C for 4 h 
to obtain the cobalt functionalized TNTs. By SEM 
imaging, the morphology of the TNTs and Co-TNTs 
were examined and analyzed using the ImageJ 
software. The pCAGGS vector containing SARS-
CoV-2 Wuhan-Hu-1 spike glycoprotein RBD was 
obtained from BEI Resources (National Institute 
of Allergy and Infectious Diseases-NIAID, National 
Institute of Health-NIH, NR-52309). The HEK293T 
cells were grown at 37°C in a humidified chamber and 
then transfected by recombinant plasmid for the His6-
tagged S-RBD protein generation. The supernatants 
from transfected cells were, then, incubated with 
1 mL of nickel-nitrilotriacetic acid (Ni-NTA) Agarose 
(Qiagen) for every 10 mL of supernatant, for 2 h at 4°C 
with rotation. The eluted protein was concentrated 
using protein concentrators, quantified using Bradford 
assay and Nanodrop (produced by ThermoFisher 
Scientific), and further analyzed by Sodium Dodecyl 
Sulphate – PolyAcrylamide Gel Electrophoresis (SDS-
PAGE).
The electrochemical sensing of S-RBD protein was 
carried out using a custom-built Co-TNT packaged 
on a printed circuit board, consisting of a clamp 
for holding the Co-TNT grown over the Ti sheet. 
The upward-facing Co-TNT side acts as a working 
electrode; vice-versa, the bottom-facing Ti side acts 
as a counter electrode.
From SEM images of Figure 7, the outer diameter 
and the wall thickness of TNTs were 60 and 10 nm, 
respectively, as well as the average length of TNTs 
was equal to about 1.1 µm. The surface morphology 
of the Co-TNT was examined, revealing the presence 
of precipitates on top of the TNT surface, as well 
as also Ehlers–Danlos syndrome (EDS) analysis 
confirmed the uniform distribution of Co ion on 
top of TNTs. The RBD of the spike glycoprotein 
(S-RBD), also comprising amino acids 329–521, 
is an easily accessible target for the detection of 
SARS-CoV-2. The ability of Co-TNT to detect the 
S-RBD protein of SARS-CoV-2 was determined by 
performing an amperometry experiment using a 
bias voltage of −0.8 V. The sensor was exposed to 
protein for 30 s after the beginning of the experiment. 
The sensor response increases rapidly, due to the 
electrochemically triggered protein unfolding and 
subsequent formation of the complex between Co 
and the protein. The average sensor response time, 
defined as the time taken to reach the peak current, 
was found to be 2 s.










where imax, base line is the maximum current obtained 
when the sensor is not exposed to the protein. The 
sensor response increased with the concentration of 
protein and the LOD can be improved using (i) Co-
TNT synthesized by an in-situ anodization technique 
and (ii) Co-TNTs with higher length. The higher sensor 
sensitivity obtained by using longer Co-TNTs results 
in a more significant reaction rate; lastly, a higher 
sensor response can be obtained even at lower 
protein concentrations.
Samson et al. (2020) provide an overview of new 
biosensors used to detect RNA-viruses, including 
nucleic-acid sensors, CRISPR-Cas9 paper strip 
sensors, antigen-Au/Ag nanoparticles-based electro-
chemical biosensors, aptamer-based bio-nanogate, 
surface plasmon resonance (SPR) sensor, and 
finally optical biosensor. These technologies could 
be useful tools for accurate, rapid, and portable 
diagnosis in the current pandemic that has affected 
the world. The sensor response is mediated by IgM 
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Figure 7: Scanning electron microscopy (SEM) micrographs of (a) TiO2 nanotubes (TNTs) 
post-annealing. Inset shows sidewalls of TNTs, (b) Co-functionalized TNTs showing the Co (OH)2 
precipitate, (c) EDS map of Co confirming its uniform distribution, and (d) EDS spectra confirming 
the presence of Co (Vadlamani et al., 2020).
and IgG antibodies, used to detect the COVID-19 
disease and used for its possible therapy, known 
as plasma therapy. To bypass the limitations of 
qRT-PCR based assay, a highly specific RT-LAMP 
(Reverse Transcription Loop-Mediated Isothermal 
Amplification) assay method is available for detection 
of SARS-CoV-2 (Park et al., 2020; Yu et al., 2020; 
Zhou et al., 2020).
Moreover, the use of modern gene-editing 
CRISPR-Cas (Clustered Regularly Interspaced Short 
Palindromic Repeats) systems was proposed to detect 
the virus, as reported in (Zuo et al., 2017). This technique 
can also detect microRNAs, bacteria, and cancer 
mutations, simply changing the target-specific crRNA/
sgRNA. The gene-editing technique was applied to a 
biological sensor-based CRISPR-Chip paired with a 
graphene-based field effect transistor (FET) to detect 
up to a 1.7 fM quantity of nucleic acid without the 
necessity for amplification and within a short span of 
15 min (Hajian et al., 2019). The FET-based biosensing 
devices employ the coating of the graphene sheets of 
the FET with a monoclonal antibody against the SARS-
CoV-2 spike protein (Figure 8).
The authors have determined the sensor 
sensitivity using antigen protein, cultured virus, 
and nasopharyngeal swab specimen provided by 
Figure 8: Schematic diagram of 
COVID-19 FET-based biosensor 
operation (Seo et al., 2020).
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COVID-19 patients. This FET biosensor can detect 
1 fg/mL concentration of SARS-CoV-2 protein in 
phosphate-buffered saline (PBS) and 100 fg/mL 
concentration in the clinical transport solution.
Recently Mahari et al. (2020) developed a home-
made biosensor device (named eCovSens) fabricated 
with fluorine-doped tin oxide (FTO) elec trode together 
with gold nanoparticles (AuNPs) and nCOVID-19 
antibody (Figure 9). This last was compared with a 
commercial potentiostat machine used to detect 
an nCOVID-19 spiked protein antigen (nCOVID-19 
Ag) in the saliva samples. A potentiostat sensor 
was fabricated using FTO electrode enriched with 
gold nanoparticles (AuNPs) and immobilized with 
nCOVID-19 monoclonal antibodies (nCOVID-19 Ab) to 
measure the changes of electrical conductivity.
Likewise, eCovSens was used to measure chan-
ges in electrical conductivity through immobilizing 
nCOVID-19 Ab on a screen-printed carbon electrode 
(SPCE). The performances of sensors were recorded 
after the interaction of nCOVID-19 Ab with an 
nCOVID-19 specimen. The FTO-based immune-
sensor and the proposed SPCE-based biosensor 
device reported high sensitivity for early detection 
of nCOVID-19 Ag, ranging from 1 fM to 1 µM (under 
optimum conditions). Furthermore, the authors 
demonstrated that the eCovSens device was able to 
successfully detect nCOVID-19 Ag with a concentration 
of 10 fM in a standard buffer. In particular, the LOD was 
90 fM with eCovSens and 120 fM with a potentiostat, in 
the case of saliva specimens. The proposed portable 
point of care (PoC) can be used for the rapid detection 
of nCOVID-19 since a 10–30 s detection time is 
ensured.
The DNA capturing sequence was immobilized on 
the silk-screened electrode surface and hybridized 
with biotinylated target strand DNA. This strategy 
could be useful for detecting the SARS-CoV-2 virus 
to change the immobilized thiolated nucleic acid 
Figure 9: Graphical representation of 
the working operation of the eCovSens 
device using SPCE electrode, including 
COVID-19 antibody (Mahari et al., 2020).
sequence. This technique is capable of detecting 
a 4.7 nM concentration of complementary nucleic 
acids.
Another electrochemical and paper-based bio-
sensor was used to detect the chikungunya virus (Zuo 
et al., 2017). These paper-based biosensors used 
the ultra-high charge-transfer efficiency of AuNPs 
associated with the magnetic NPs (Fe2O4). This 
electrochemical biosensor is simple, biodegradable, 
and economical. In this scenario, another novelty 
concerns a novel DNA hydrogel formation by 
isothermal amplification of the complementary target 
(DhITACT-TR) system, which has been successfully 
used to detect the MERS (Middle East Respiratory 
Syndrome) virus. This methodology is featured by 
high sensitivity, rapid detection time and easy use 
since the result, based on fluorescent emission, can 
be diagnosed by the naked eye (Figure 10) (Jung 
et al., 2016).
In conclusion, traditional techniques, like PCR and 
sequencing, are time-consuming, and might not fulfil 
the new challenges (such as rapid mutations) and 
demands (for mass populations) for the faster and 
direct detection of viral pathogens.
Mauriz (2020) explored the recent progress of 
the plasmonic nanostructures applications for virus 
detection, which has lately gained great attention, due 
to their versatility, low time of response, and label-free 
Figure 10: DhITACT-TR chip for robust 
detection of target pathogen in a 
single-step injection of RNA extract 
(Samson et al., 2020).
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monitoring. Also, their potential for multiplexing and 
system miniaturization are additional benefits for PoC 
testing. These features, along with the possibility of 
taking advantage of nanomaterials’ electronic and 
physical properties, have allowed the creation of 
smaller and ultrasensitive detection frameworks. 
Therefore, nanoplasmonic biosensors seem to re-
present an excellent approach to ensure ultra-low 
detection limits of viral particles, antigens, or nucleic 
acids from clinical samples (i.e., blood, serum, saliva, 
etc.). Most of the plasmonic applications for virus 
sensing rely on the well-known operation principles of 
SPR, but, to obtain optimal performance, new design 
strategies are required to maintain the sensitivity and 
specificity of measurements, as well as preserving 
the biocompatibility of the immobilized biological 
receptor. These plasmonic biosensors exploit pro-
pagation of surface plasmons along with the interface 
of a thin metal layer (commonly noble metal), and a 
dielectric (aqueous medium).
In other terms, the plasmonic biosensor takes 
advantage of the local refractive index changes of 
the transducer surface during the monitoring of the 
molecular interactions among the target analyte and 
the immobilized biological receptor. The binding 
events occurring on the surface can be monitored 
in two different forms: SPR and localized surface 
plasmon resonance (LSPR), both functions of the 
surface refractive index. However, the dimension 
of the plasmonic nanomaterial is very important for 
determining the difference between SPR (based 
on thin metallic layers) and LSPR approaches. In 
particular, the latter is featured by dimensions lower 
than the incident wavelength (Figure 11).
This characteristic allows controlling the spatial 
resolution of LSPR configurations by designing the 
geometry and composition of metallic nanostructures. 
The local electromagnetic field can optimize the 
optical processes such as the fluorescence and 
Raman scattering, leading to Surface-enhanced 
Raman Scattering and plasmon-enhanced electro-
chemiluminescence sensing schemes. The sensitivity, 
achieved by both the optical configurations, is higher 
than those of both SPR and LSPR.
For example, a new approach combines the 
effect of plasmonic photothermal (PPT) and LSPR 
sensing, to detect DNA-selected sequences via 
the hybridization of DNA receptors immobilized 
on two-dimensional gold nano-islands (AuNIs). 
This plasmonic dual-functional biosensor takes 
advantage of the PPT heat generated on the AuNIs’ 
chip to increase the hybridization temperature and 
discriminate two similar gene sequences (RNA-
dependent RNA polymerase RdRp genes) from 
Figure 11: The surface plasmon polariton (SPP) can only be excited at specific wave vectors and 
decays evanescently from the surface. The momentum-matching condition leads to the SPP 
resonance and only exists at certain incident angles (Li et al., 2015).
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Figure 12: Different technologies versus 
the COVID-19 (Chamola et al., 2020).
SARS-CoV and SARS-CoV-2. A detection limit of 
0.22 pM was obtained using a multigene mixture 
including DNA sequences of the RdRp-COVID, an 
open reading frame 1ab (ORF1ab)-COVID nucleic 
acid, and E genes from SARS-CoV-2.
Another innovative approach for COVID-19 de-
tection is the colorimetric assay. This approach is 
based on gold nanoparticles (AuNPs), functionali-
zed with thiol-modified antisense oligonucleotides 
(ASOs) specific for N-gene (nucleocapsid phos-
phoprotein) of SARS-CoV-2 (Moitra et al., 2020). 
The biosensing scheme comprised the change 
of its SPR absorbance spectra with a redshift of 
~40 nm when thiol-modified AuNPs agglomerates 
selectively with their target RNA sequence. This 
application demonstrated that the addition of 
endonuclease Ribonuclease (RNAse H) brings to a 
visually detectable colorimetric change thanks to the 
aggregation with the AuNPs. The assay selectivity 
was tested in the presence of MERS-CoV viral RNA, 
showing a LOD of 0.18 ng µL−1 of RNA with SARS-
CoV-2 viral load. The principal advantage of the 
proposed method is its capability to target other 
regions of viral genomic material, such as E-gene 
(envelope protein), S-gene (surface glycoprotein), 
and M-gene (membrane glycoprotein) without using 
sophisticated instrumental techniques.
IoT solutions and systems for  
monitoring and limiting the COVID-19 
pandemic spreading
COVID-19 has pushed the scientific community 
around the world to create, improve, and communi-
cate heterogeneous systems to minimize the virus’s 
impact on our lives. This paragraph explored the 
new technologies for monitoring, detecting, and 
containing the spreading of COVID-19 pandemic. 
In particular, we have investigated the Internet of 
Things (IoT) solutions for early detecting the onset of 
the infection symptoms, such as fever and breathing 
problems (Figure 12).
Otoom et al. (2020) proposed a real-time COVID-19 
tracking and detection system that uses an IoT archi-
tecture for collecting real-time symptoms data from 
infected users (Hernández and Sallis, 2020; Jung, 
2020) and for the following aims (Figure 13).
•	 Rapidly identifying suspected coronaviruses 
cases,
•	 Monitoring the response to the treatment of in-
fected patients, and
•	 Understanding the symptoms of the virus by 
collecting and analyzing relevant data.
The framework consists of these five sections:
1.  Symptom Data Collection and Transfer section 
(using wearable devices),
2. Quarantine/Isolation Center,
3.  Data Analysis Section, based on machine 
learning (ML) algorithms,
4. Health Physicians Section, and
5. Cloud Infrastructure.
We know that the most relevant COVID-19 
symptoms are as follows: fever, cough, fatigue, sore 
throat, and shortness of breath. To rapidly identify the 
potential coronavirus cases from the real-time data 
Figure 13: Representation of IoT-based 
framework for early identification and 
monitoring of new cases of COVID-19 
virus infections (Otoom et al., 2020).
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collected, the use of eight ML algorithms, namely 
Support Vector Machine (SVM), Neural Network, 
K-Nearest Neighbor (K-NN), Naïve Bayes, Decision 
Stump, Decision Table, ZeroR, and OneR is proposed. 
The system in question could be implemented with 
an IoT infrastructure to monitor both potentials and 
confirmed cases. In addition to the real-time monitoring 
function, this system can contribute to understanding 
the virus nature by collecting, analyzing, and archiving 
the critical data.
Among the framework components, there is also 
the Quarantine/Isolation Center; this component 
records data from users who have been quarantined 
or isolated in a health care centre. These records 
include health (or technical) data, which refer to the 
symptoms mentioned above, and non-technical 
data related to travel and contact history during the 
past 3–4 weeks, chronic diseases, gender, age, 
and other relevant information, such as the family 
history of illness. Another essential component is the 
Data Analysis Center; it hosts data analysis and ML 
algorithms used to build a model for COVID-19 and 
provide a real-time dashboard of the processed data. 
The model can also predict the patient treatment 
response. In addition , by the proposed ML-based 
identification/prediction mode, physicians will be 
able to monitor suspected cases whose real-time 
uploaded symptom data should indicate a possible 
infection.
The last component is the Cloud Infrastructure, 
interconnected through the internet, for uploading 
real-time symptom data from each user, maintaining 
personal health records, communicating prediction 
results, sharing physician recommendations, and 
providing information to be stored. The results 
showed that all ML algorithms used in this work, 
except the Decision Stump, ZeroR, and OneR, 
achieved accuracies above 90%; thus, the best 
algorithms would provide an effective and accurate 
identification of COVID-19 cases.
Maghded et al. (2020) described various deve-
loped techniques to detect the initial symptoms of 
the COVID-19 virus, such as medical detection kits. 
In this work, a new framework is described to detect 
the virus using the built-in smartphone sensors and 
predict the gravity grade of pneumonia to predict the 
disease outcomes. Modern smartphones integrate 
numerous sensors with powerful computation capa-
bilities, allowing them to sense information about 
daily activities and even capture visual data. Since 
each symptom has its danger level different from 
other diseases, the framework tries to discover 
each symptom’s level based on the built-in sensors 
measurements (Figure 14).
The proposed framework integrates the data, 
acquired by sensors installed on recent smartphones, 
with algorithms in a single solution, deriving a pre-
dicted level of symptoms and storing them in a 
dataset as a single record. Therefore, such records 
from different patients are collected and used as 
input to a ML algorithm. The authors proposed a 
framework that consists of a set of layers. The first 
one is responsible for gathering data from sensors: 
reading the captured computed tomography (CT) 
scan images of lung acquired by the smartphone 
camera; getting the inertial sensors (accelerometer 
sensor) data over 30-second sit-to-stand; recording 
microphone voice for a series of cough; finally mea-
suring the temperature during fingerprint touching on 
the smartphone screen.
The second layer configures the onboard smart-
phone sensors, including image size, reading in-
tervals, timer resolution, buffers’ size, etc. Afterward, 
the readings and configurations are used to input the 
symptoms algorithms running on the smartphone 
application. The third layer of the framework calculates 
the danger levels of symptoms separately and then 
stored them as a record input to the next layer. Mean-
while, according to the nature of recorded data, the last 
layer applies ML techniques to detect the COVID-19. In 
addition, to improve the proposed framework and get a 
reliable prediction result, the recorded information and 
the results from different users or patients are shared in 
the cloud; thereby, a large data set is obtained. Such a 
process will also provide transfer learning from multiple 
smartphones and various onboard sensors to new 
smartphones (Figure 15).
In conclusion, the proposed framework is imple-
mented in a mobile app to verify the acquisition fun-
ctions of COVID-19 symptoms used in the diagnosis 
Figure 14: Scheme of the proposed 
framework to predict COVID-19 
(Maghded et al., 2020).
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Figure 15: Cloud computing for the 
proposed framework (Maghded et al., 
2020).
Figure 16: User registration & results of the test (Maghded et al., 2020).
process. Figure 16 shows two screenshots related to 
the registration page and the transfer of the acquired 
data to the cloud platform.
Sun et al. (2020) analyzed the data through 
the smartphones and wearable devices on 1062 
participants recruited in Italy, Spain, Denmark, UK, 
and the Netherlands. Daily, they derived nine functions, 
including time spent at home, maximum distance 
traveled from the user residence, the maximum number 
of Bluetooth-enabled nearby devices (as a proxy for 
physical distancing), step count, average heart rate, 
sleep duration, bedtime, phone unlock duration, and 
social app use duration.
As expected, following the respective national 
lockdowns and consequently the severe penalties 
for violating the imposed protocols, people stayed 
home longer, so people made connections with fewer 
Bluetooth devices nearby. Table 2 shows a complete list 
of features: location data derived from the smartphone 
was sampled once every 5 min, with longer sampling 
durations depending on network connectivity. Spurious 
location coordinates were identified and removed if 
they differed by more than five degrees from preceding 
and following coordinates (Table 2). Through the 
Kruskal–Wallis tests followed by posthoc Dunn’s tests, 
the authors examined changes in mobility, functional 
measures, phone usage induced by the lockdowns, 
and the comparisons among baseline pre and during 
the lockdown on the daily median of each feature. 
These quantities were also analyzed by differentiating 
them by age, sex, body mass index, and educational 
background. The RADAR-Base open-source mHealth 
platform managed the data collection and manipulation. 
This last is an open-source platform that supports the 
collection and analysis of mobile and telephone data in 
real-time, so allowing immediate intervention.
Given the streaming nature of the platform, it is 
easy to provide insights into the data in real-time, 
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thus making the results potentially usable for localized 
monitoring. In fact, through RADAR-based measures, 
they quantified changes in mobility, phone use, and 
functional measures as a result of non-pharmaceutical 
interventions introduced to control COVID-19 diffusion. 
Finally, the RADAR-based system has proven itself 
capable of collecting data from wearables and 
mobile devices to determine the health system’s res-
ponsiveness against the COVID-19 outbreaks. This 
capacity to monitor the reactions to interventions in 
real-time is essential to understand the behavior of the 
COVID19 disease.
Nasajpour et al. (2020) have examined the role of 
IoT-based technologies in COVID-19 and reviewed the 
state-of-the-art architectures, platforms, applications, 
and industrial IoT-based solutions for combating 
COVID-19 in three main phases, including early 
diagnosis, quarantine time, and after recovery. During 
this pandemic, wearable devices are an efficient 
way to respond to the need for early diagnosis. For 
example, a wide range of IoT smart thermometers 
has been developed to record the patients’ body 
temperature continuously because the use of these 
should decrease the spread of the virus as it is not 
necessary for health workers to be in close contact 
with patients (which happens using the old types of 
thermometers). These low-cost, accurate, and easy-
to-use devices could be worn or stuck to the skin 
under clothing. Other smart thermometers can report 
body temperature at any time on a smartphone, like 
Tempdrop, Ran’s Night, iFever, and iSense (Figure 17).
Another innovative device to detect body tem-
perature is the Smart Helmet, which is useful since 
it is safer than an infrared thermometer gun due to 
lower human interactions (Triaxtec, 2019). In this 
device, when the thermal camera detects the high 
temperature on the Smart Helmet, the position and 
Table 2. A full list of extracted features (Sun et al., 2020).
Category Modality Features Extraction
Mobility Smartphone location Homestay The time spent within 200m radius of home 
location (determined using DBSCAN)
Maximum traveled  
distance from home




Maximum number of 
nearby devices
The maximum number of Bluetooth-enabled 
nearby devices
Fitbit step count Step count Daily total of Fitbit step count
Functional 
measures
Fitbit sleep Sleep duration Daily total duration of sleep categories (light, 
deep, and rem)
Bedtime The first sleep category of the night
Fitbit heart rate Average heart rate The daily average heart rate
Phone usage Smartphone user 
interaction




Social app use duration The total duration spent on social apps (Google 
Play categories of Social, Communication, and 
Dating)
Figure 17: iFever (a), Tempdrop (b), 
iSense (c), Ran’s Night (d), and smart 
thermometers.
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the picture of the person’s face are taken by an 
optical camera and transmitted to the determined 
mobile device with an alarm (Figure 18).
Moreover, Google Location History can be incor-
porated with the Smart Helmet to find the places 
attended by a suspected or infected person, and 
additionally can enhance further actions with more 
reliability by capturing the suspicious case sites 
(Calabrese et al., 2020).
Another example is Vuzix smart glasses (https://
www.vuzix.com/) with the Onsight Cube thermal 
camera. These devices, produced by Vuxis, can 
monitor crowds to detect people who have high 
temperatures and send the information to the medical 
Center (Figure 19) (Mohammed et al., 2020).
Other studies have shown how, by using 
Unmanned Ariel Vehicles (UAVs) and in particular IoT-
based drones, it is possible to speed up the process 
of finding people affected by CoVID-19 and monitor 
areas without risk of contamination (Chamola et al., 
2020). There are various categories of the drone: 
Figure 18: Smart Helmet captures 
temperature by the thermal optical 
camera (Triaxtec, 2019).
Figure 19: Smart glasses temperature 
capturing (Mohammed et al., 2020).
Figure 20: Thermal imaging drone 
(Hitconsultant, 2019).
Disinfectant Drone and Medical/Delivery Drone. An 
example is a drone shown in (Figure 20), designed to 
capture people’s temperature in a crowd and be used 
in the early diagnosis phase.
Robots have also had a significant impact in this 
context, both for the diagnosis process by collecting 
swabs, and later to assist patients. An example of 
this device, the robot named Intelligent Care Robot 
(Figure 21) developed through a partnership between 
Vayyar Imaging and Meditemi companies. This robot 
allows detecting symptoms related to COVID-19 in 
10 s using a quick scan without coming into contact 
with the patient.
Chamola et al. (2020), in association with the 
Cleveland Clinic, used physiological data, gathered via 
the wrist-mounted WHOOP Strap 3.0, from hundreds 
of WHOOP members who identified themselves as 
infected by COVID-19. The strap can notify the user 
of any issues that they might experience. This device 
also allows to remotely monitor the employees’ health 
status and keep a record of any case of COVID-19 
Figure 21: Autonomous swab test 
robots (South Korean Institute of 
Machinery and Material, 2019).
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transmission amongst them. When this device 
is turned on, it scans for other wearable devices 
and records any close interactions with them. The 
device includes a passive GPS location-tracker and 
Bluetooth-based proximity sensors, ultra-wideband 
connectivity, built-in LTE (Long-Term Evolution), and a 
rechargeable battery. Since it is essential to control 
the disease spread, the wearer can update his health 
according to three different possibilities (certified 
healthy, symptomatic, or infected verified), recorded 
in a central database able to store information for 
up to 6 weeks. Rapid diagnosis of the COVID-19 
can allow governments to take effective response 
measures to limit the virus spreading. The lack of 
testing kits in the world has made it hard for the 
authorities to carry out large-scale diagnostic testing. 
Therefore, to limit the exposure of frontline personnel 
to COVID-19 patients, many hospitals and airports 
have adopted the use of cameras with multi-sensory 
technology based on artificial intelligence (AI). These 
cameras allow authorities to observe crowds, identify 
people with high body temperatures, recognize their 
faces, and track their movements. For example, 
the Tampa General Hospital in Florida (USA) has 
installed a camera that uses AI technologies at its 
entrance to screen all patients entering the facility by 
performing a thermal scan of the face. The AI system 
uses ML of camera-detected results to classify 
whether or not an individual exhibits symptoms of 
COVID-19. In conclusion, voice detection is one 
of the easy technologies that can be employed to 
identify potential COVID-19 patients. During these 
difficult times, voice detection platforms can act as a 
screening measure to decide who needs to be tested.
Stojanović et al. (2020) presented a wearable 
system/device capable of tracking critical COVID-19 
symptoms. It allows monitoring body temperature, 
heart rate, respiration rate, and other vital signs, 
which are essential to alert patients and remote 
medical staff about unusual symptoms correlated to 
COVID-19 or similar diseases. The simplest sensor 
consists of any mobile phone with a standard 
headset with a built-in microphone. It takes over 
breathing problems, respiration rate, and cough. It is 
attached to microphone/speakers input through the 
3.5 mm jack. The built-in microphone records every 
audio signal on the mobile phone, then imported 
and processed with processing software, such as 
MATLAB, both in the time and frequency domain. It 
can detect the analyzed audio signal characteristics 
such as respiratory rate, rapid or shortened breathing, 
and cough. The user receives audio feedback via 
earphones, such as an audible alarm, when the 
respiratory rate is above or below the threshold, or 
some breathing problems such as rapid breathing 
or heavy cough, are present. The authors proposed 
another extended configuration, equipped with more 
sensors interfaced with a mobile app and managed 
by an Arduino board.
The temperature sensor (a PTC or NTC thermistor) 
is integrated into the earphone, whereas the heart 
rate sensor is in the form of Photoplethysmography 
(PPG) clips applied to the ear lobes. Respiratory rate 
and body temperature are measured by using the 
microphone and thermistor. The headset was then 
modified mounting the thermistor on the capsule’s 
surface, and the second speaker was replaced with 
the PPG clip. Simple standard circuits amplify the 
signals based on operational amplifiers before they are 
acquired and processed by the Arduino. The significant 
part of the pre-processing (low and high pass filtering, 
envelope detection, signal smoothing, and threshold, 
etc.) is performed by amplifiers (Figure 22).
Filters are software implemented, in integer 
arithmetic, to be fast and with low memory usage. The 
locations of the heart rate and respiratory rate peaks 
are calculated from the spectrum obtained with the 
Fast Fourier Transform (FFT). Due to limited memory 
resources, FFT is implemented on the Arduino, with 
integer arithmetic. The microphone signal envelope 
detector is then implemented by the amplifiers, 
converting the audio signal into a low-frequency 
signal, reducing the sampling frequency to 25 Hz. The 
same sampling rate is used for processing the four 
signals. Figure 23 shows the Arduino interface based 
on signal acquisition filters.
Singh et al. (2020) developed an IoT-based wearable 
quarantine band (IoT-Q-Band) to detect absconding. 
Designing it, they kept in mind the cost, global supply 
chain disruption, and COVID-19 quarantine duration, 
according to the World Health Organization (WHO) 
recommendations. IoT-Q-Band is a low-cost solution 
that could benefit low-income regions to prevent the 
spread of COVID-19 (Figure 24).
This wearable prototype reports and tracks the 
absconding quarantine subjects in real-time through 
a mobile app. The wearable strap is worn by a 
quarantined subject on the hand, arm, or leg and 
connected through wireless to the mobile application 
via a Bluetooth link. After tampering with the band, 
the latter transmits the status (one byte of data) to the 
mobile application every 2 min. The subject will be 
registered in the IoT-Q-Band system by the relevant 
medical authority, responsible for the duration of the 
quarantine and other details. During the registration 
phase, the system stores the GPS coordinates of 
the position where the quarantine will be carried out. 
The mobile application provides the following visual 
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Figure 22: The configuration of the headset’s microphone for the respiration rate and breathing 
detection, (a) configuration of the heart rate, temperature, and respiration rate detection using 
NTC thermistor, microphone, and PPG sensor, (b) (Stojanović et al., 2020).
Figure 23: Block diagram of the Arduino based interface for processing vital signs (Stojanović  
et al., 2020).
feedback: (1) if the wearable strap is working or is 
tampered with, (2) if the subject is within 50 meters 
(geo-fencing) of the recorded quarantine location, and 
(3) the remaining time of quarantine. After the subject’s 
registration, the mobile application pushes a Javascript 
Object Notation (JSON) packet to the cloud server 
containing information about the wearable band’s 
state and GPS coordinates (Figure 25).
The IoT-Q-Band relies on the ESP32 chip sewn 
onto a 6 cm wide strip of fabric. It is covered so that 
the user is comfortable wearing it, and the tamper 
detection wire is soldered to a ground pin and sewn 
to the material. The other end of the tamper detection 
cable is plug-n-play and connects to a digital input/
output (DIO) pin, programmed as an input (with the 
internal pull-up resistor enabled) (Figure 26).
The IoT-Q-Band is securely and comfortably 
attached to the wrist or legs with Velcro strips. IoT-
Q-Band system has three visual indicators related to:
•	 The tampering of the IoT-Q-Band and the main 
indicator changes color from green to red;
•	 The drifting apart of the subject over 50 meters 
from the memorized quarantine position (dur-
ing initial recording) and the central indicator 
changes color from green to red; and
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•	 The patient data is not updated in the last 
10 min (calculated based on the timestamp of 
the last received packet).
Finally, the authors discovered that while trans-
mitting a byte of data, the current consumption stays 
at 100 mA for 8 s. In contrast, setting a detection 
period of 2 m, the IoT-Q-Band consumes 30 mA 
for 112 s and 100 mA for the next 8 s, and thus, the 
average current consumption by the band is just 
34.66 mA. In addition, they found that the GPS 
location uncertainty reported through a smartphone 
generally depends on the surroundings or the mea-
surement environment.
Han et al. (2019) proposed a new clustering model 
for medical applications (CMMA) to select the cluster 
head and provide energy-efficient communication 
in the telemedicine scenario. Specifically, the system 
Figure 24: The system architecture of the IoT-Q-Band system (Singh et al., 2020).
Figure 25: Data flow diagram of the IoT-Q-Band system (Singh et al., 2020).
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Figure 26: Mobile application screens of the IoT-Q-Band system showing the cases: (a) when the 
band is connected, and the subject is within 50 meters of registered quarantine Geo-location, 
and (b) when the wearable tampered, and the patient is outside the 50 meters of the registered 
quarantine Geo-location (Singh et al., 2020).
chooses the device with the higher remaining energy 
level and closer to the base station. The authors have 
demonstrated that the proposed CMMA presented 
better sustainability and energy-efficiency compared 
to other considered solutions (i.e. Low Energy 
Adaptive Clustering Hierarchy-LEACH, Particle Swarm 
Optimization-PSO, gravitational search algorithm-
GSA). Furthermore, Fei et al. (2006) introduced a 
custom routing framework for collecting biophysical 
data from portable and wearable devices, allowing 
high-efficiency data queries. A crucial topic related 
to telemedicine IoT systems concerns information 
security, given the sensitivity of the data processed 
(Zhang et al., 2020). However, energy-efficient data 
encryption systems are needed since wearable, 
low-power, and battery-limited devices are typically 
involved in these applications (Pirbhulal et al., 2017). 
For instance, Pirbhulal et al. (2017) introduce an 
efficient and reliable IoT smart home automation 
system, supported by a WSN; the data encryption 
system employs a triangle-based security algorithm 
(TBSA) method to make efficient the key generation 
step. The developed proof-of-concept demonstrated 
that the proposed TBSA algorithm is more energy-
efficient than other approaches. Similarly, Snader et al. 
(2016) created an energy-efficient, secure, and agno-
stic encryption protocol properly designed for IoT 
healthcare applications. The obtained results indicated 
excellent performances and reduced overhead, esse-
ntial requirements for wearable or portable devices.
Currently, the WHO advises those in direct 
contact with coronavirus patients and with people 
who cough to wear a face mask. Stanford et al. 
(2019) described a self-cleaning filter composed of 
laser-induced graphene (LIG), which can capture 
bacteria and particulates, and a conductive graphene 
foam formed through the photothermal conversion 
of a polyimide film by a commercial CO2 laser cutter. 
This filter readily reaches a temperature greater than 
300°C by a periodic Joule-heating mechanism. This 
mechanism can destroy bacteria and molecules that 
cause adverse biological reactions and diseases 
(pyrogens, allergens, exotoxins, endotoxins, mycoto-
xins, nucleic acids, and prions). Using thermal sta-
bility and the high surface area of LIG, the utility of 
graphene for reducing infection in hospital settings 
is suggested. This filter shows a modest electrical 
conductivity that enables the filter to be Joule-heated 
by electrical power dissipation. Figure 27 shows the 
filter testing setup and the working principle for self-
sterilization of the filter.
The authors demonstrated that LIG can capture 
bacteria and prevents proliferation, even when 
submerged in a culture medium. The filter overcomes 
the traditional filters and disinfection methods, as 
the self-sterilization by Joule-heating can avoid the 
accumulation of microorganisms on the filter and 
subsequent downstream contamination.
A new graphene-based mask named Guardian 
G-Volt, produced by LIGC Applications, is based 
on the same principle above described (Figure 28) 
(Dezeen, 2019). LIGC Applications claims that the 
adopted graphene-based filtration system is 99% 
effective against particles over 0.3 µm and 80% 
against anything smaller. Compared to an N95 
breathing mask, it blocks 95% of particles over 
0.3 µm. A low-level current will pass through the 
Guardian G-Volt when connected to a portable 
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Figure 27: Representation of filter testing setup and the working principle for self-sterilization of 
the filter (Stanford et al., 2019).
Figure 28: Example of the Guardian 
G-Volt mask application (Dezeen, 
2019).
battery pack via a USB port. This charge would repel 
the particles trapped in the graphene mask. At home, 
a docking system allows the mask to be sterilized, to 
be worn again. Graphene, a material with impressive 
characteristics, is naturally antibacterial, so Guardian 
G-Volt can also protect the wearer from bacteria. 
The graphene in the mask is a type called LIG. This 
microporous conductive foam can trap bacteria and 
conduct the electricity needed to sterilize the mask’s 
surface.
Another significant step beyond has been done by 
Philips, which developed a next-generation wearable 
biosensor to detect patient deterioration, including 
clinical surveillance for COVID-19 (Philips, 2019). The 
Philips Biosensor BX100 (Figure 29a) enhances clinical 
supervision of patient deterioration, reducing the risk 
to intervene earlier and improving care for patients 
in low acuity care areas. The solution received a CE 
mark and is currently in use at the Onze Lieve Vrouwe 
Gasthuis (OLVG) hospital in the Netherlands to monitor 
COVID-19 patients.
The Philips Biosensor BX100 is designed to 
address a new approach to vital signs measurements. 
It is a single-use wearable patch with 5-day autonomy, 
combined with a scalable hub to monitor several 
patients across multiple rooms. The scheme related 
to the monitoring system’s operation is reported in 
Figure 29c.
The Philips Biosensor BX100 device does not 
require cleaning or charging and can be included 
in existing clinical workflows for surveillance and 
notifications tasks. The wireless wearable biosensor 
is applied to the chest (Figure 29b). Every minute, 
it enables to collect, measure, store, and send 
respiratory rate, heart rate, and contextual parameters 
(i.e., posture and activity level).
Performance and comparative  
analysis of discussed systems,  
sensors, and technologies
This section provides a comparative analysis of the 
sensing solutions and technologies described in the 
second section, for detecting patients affected by 
the COVID-19 virus, pointing out the performance 
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Figure 29: BX100 Philips Biosensor (Philips, 2019): front view of the device (a), and its application 
on a patient (b), the graphical scheme of the health monitoring system (c).
evaluation mechanisms, application scenarios, target 
species, advantages, and limitations, to determine 
the most promising tools to face future pandemics.
In the second section, we have extensively analyzed 
the different magnetic biosensor technologies, which 
shows, also at low analyte’s concentration, higher 
sensitivity than other detection methods, such as the 
standard fluorescent system (Schotter et al., 2004). 
Furthermore, the magnetic biosensors present a 
lower background noise compared to other sensor 
technologies, such as the optical-based ones 
(Srinivasan et al., 2009), and intrinsic compatibility with 
the micro and nanofabrication technologies, making 
them suitable for the realization of sensor arrays 
on a single chip enabling parallel detection. The MR 
biosensors, including GMR and NMR, are typically 
featured by moderate MR ratio and good linearity, but 
suffer from intrinsic fragility and reduced MR ratio at 
high temperature. The electrochemical biosensors are 
featured by high sensitivity, fast response time, good 
selectivity, and simple miniaturization (Menon et al., 
2020). However, this biosensors typology shows a 
limited shelf life, and a sensitivity affected by sample 
matrix and temperature, inducing the antibodies 
deterioration, thus corrupting the sensor operation. 
The plasmonic biosensors are very sensitive to small 
sample changes and repeatable, as well as do not 
require a calibration model given to the conventional 
electrical model (Villena Gonzales et al., 2019). 
However, they are susceptible to motion, temperature, 
and sweat, and need a long calibration process.
Given the advantages and disadvantages of the 
analyzed technologies, the next step is to compare 
the scientific works discussed in the second section 
to bring out differences and potentialities for defining 
the future generation of rapid virus’ assay methods. 
Table 3 shows a comparison between different 
biosensors and bio-detectors in terms of the detection 
technology, target species, LOD, application scenario, 
and scalability, intended as the ability of the detection 
system to be applied to a broad audience of users.
Specifically, despite their high sensitivity, the GMR 
and NMR detection methods are time-consuming, 
require multiple washing steps during the detection 
process, hence the use of specialized staff, and 
involve a high cost for every test, taking into account 
the bio-detector cost, thus reducing the technology 
scalability. The NMR detection method is typically 
featured by a sensitivity lower than both GMR and 
MPS techniques, entailing the same practical issues 
related to the washing steps, that reduce the system 
sensitivity.
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The electrochemical biosensors are considered 
one of the most promising clinical diagnosis and 
point-of-care detection technologies, essential for 
applications such as rapid drug tests, food moni-
toring, glucose detection, etc. (Menon et al., 2020). 
Their compatibility with fabrication techniques, like 
screen printing based on carbon nanoparticles, 
opens a new frontier toward developing low-cost, 
reliable, rapid, and disposable clinical tests that 
offer results similar to the standard approaches 
(Chin et al., 2017). The FET-based biosensors 
provide numerous benefits, like high sensitivity and 
the capability to carry out real-time measurements 
with a reduced amount of analytes. Besides, the 
graphene-based FET biosensors represent a 
promising solution for realizing biological assays 
for clinical diagnosis of diseases, such as cardiac 
diseases, kidney injury, diabetes, cancers, infla-
mmatory, and infectious diseases, exploiting the 
conductivity and large area featuring the graphene. 
These devices show optimum sensitivity, real-
time detection, and low production costs, allowing 
the realization of disposable biological assays for 
mass screening in pandemics or other diseases. In 
the last years, several efforts have been made for 
overcoming some issues affecting the FET-based 
biosensors related to sensitivity and response time 
due to the minimum obtainable subthreshold swing 
(Sarkar and Banerjee 2012). The SPR and LSPR 
biosensors are characterized by very high sensitivity, 
accuracy, and real-time detection of unknown 
analytes (Esfahani Monfared, 2020). Nevertheless, 
the plasmonic biosensors usually employ an optical 
substrate in the form of a glass/polymer prism to 
couple the light emitted by a laser source with the 
surface oscillations, an arrangement known as the 
Kretschmann configuration. This configuration is 
bulky and difficult to integrate into a compact setup, 
reducing the applicability of plasmonic biosensors 
for POC testing.
Conclusions
The manuscript aims to explore the technologies 
and systems employed to fight against COVID-19 
diffusion. At first, we investigated the methodologies 
Table 3. Comparison between the scientific works reported in the second section, in 













Wu et al. (2020) GMR H1N1 virus H3N2 
virus
15 ng/mL 125 
TCID50/ml
10 min Virus screening Low
Orlov et al. (2016) MPS BoNT A, B and E 0.22, 0.11, 
0.32 ng/mL
25 min Food quality Medium
Zhang et al. (2013) MPS ssDNA 400 pM 10 sec DNA analysis Medium




Zhao et al. (2021) electrochemical SARS-CoV-2 
virus
200 copies/mL 10 sec Virus screening High




14 nM 30 sec Virus screening High
Chin et al. (2017) electrochemical JEV virus 5–20 ng/mL 20 min Virus screening High
Seo et al. (2020) FET-based SARS-CoV-2 
virus
1.7 fM 20 sec Virus screening High
Moitra et al. 
(2020)
LSPR SARS-CoV-2 0.18 ng/µL 10 min Virus screening Low
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and the related instrumentations to carry out rapid 
and reliable assays to identify the infected subject, 
thus breaking the contagion chain. Specifically, we 
focused on the magnetic biosensors technologies, 
including MR sensors, MPS, and NMR platforms, 
offering several advantages compared to plasmonic, 
electrochemical, and optical sensors, such as lower 
background noise and influence of sample matrix 
typology. Furthermore, magnetic-based detection 
sensors can be easily combined with compact and 
portable readers, thanks to the availability of a low-cost 
and high-performance processing platform, allowing 
the rapid testing of large numbers of people. Besides, 
we have analyzed novel solutions of electrochemical 
and plasmonic biosensors for detecting the SARS-
CoV-2 virus, featured by high reliability and low-cost. 
To become competitive with other analysis techniques 
(e.g., fluorescent spectroscopy), it is needed to in-
vestigate functionalized magnetic nanomaterials to 
carry out a multi-analyte detection strategy. Besides, 
in the next future, we forecast the development of 
fully integrated, disposable, and label-free magnetic 
sensors without the need for an MNP detector; 
these biosensors require the implementation of novel 
and low-cost microfluidic structures and a suitable 
integration of the electronic sections. Thanks to their 
potentialities, the electrochemical biosensors re-
present the most promising solution for point-of-care 
and rapid diagnosis of infectious diseases to contain 
future pandemics. However, the development of new 
engineered nanomaterials for signal amplification 
constitutes a powerful solution for improving de-
vice performances (Kumar et al., 2019). The SPR 
instrumentations are still relatively cumbersome and 
expensive, making them not adequate for a portable 
diagnosis system. Therefore, several studies must be 
addressed to integrate alternative light sources (e.g., 
LEDs) and detectors (e.g., CMOS sensors) to reduce 
the size and cost of the SPR detector (Liu et al., 2015). 
A further challenge to be faced concerns the limited 
multiplexing capability of SPR devices, which requires 
multi-sensor chips and multiple microfluidic sensing 
channels (Li et al., 2020; Taylor et al., 2006).
Also, the latest devices and IoT architectures 
for containing the COVID-19 spreading have been 
investigated. In particular, we analyzed the solutions 
for limiting the contagion, and those to rapidly 
screen a large number of people for detecting the 
suspected people based on the symptoms featuring 
the COVID-19 infection, such the fever and breathing 
problems. Furthermore, we explored innovative IoT 
frameworks for remotely detecting and monitoring 
the user’s vital signs to prevent and eradicate the 
COVID-19 virus or similar disease.
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